Summary
PointClickCare (NASDAQ:PCLK) wants to raise $100 million in an IPO. 
The company offers a purpose-built integrated software suite focused on the needs of growing healthcare markets.
PCLK is growing well, with high gross margins and positive-trending cash flows.
Assuming an IPO valuation of $400 million, I recommend buying the stock.

